Windlas Biotech Ltd - 543329 - Corrigendum To The Outcome Of The Board Meeting Dated November 08, 2022.
Corrigendum to the Outcome of the Board Meeting dated November 08, 2022. related buy-back announcement09-11-2022
09-11-2022
Windlas Biotech Ltd - 543329 - Statement Of Deviation(S)
Statement of deviation(s) or variation(s) under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 201908-11-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Report of the Monitoring Agency08-11-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
press release on un-audited Standalone and Consolidated Financial Results for the Quarter ended September 30, 202208-11-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation
Results Presentation for the Quarter and Half Year ended September 30, 202208-11-2022
Windlas Biotech Ltd - 543329 - Financial Results September 2022
Outcome of the meeting of the Board of Directors of Windlas Biotech Limited ('the Company') in terms of Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.08-11-2022
Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Outcome Of The Board Meeting For Financial Results And Buyback
Outcome of the meeting of the Board of Directors of Windlas Biotech Limited ('the Company') in terms of Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.08-11-2022
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference Call to discuss financial performance for quarter ended September 30, 202205-11-2022